A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia

被引:62
作者
Miserez, AR [1 ]
Muller, PY
Barella, L
Schwietert, M
Erb, P
Vernazza, PL
Battegay, M
机构
[1] Univ Basel, Dept Clin Biol Sci, Basel, Switzerland
[2] Univ Basel, Inst Med Microbiol, Basel, Switzerland
[3] Univ Basel Hosp, Div Endocrinol Diabetol & Clin Nutr, CH-4031 Basel, Switzerland
[4] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[5] Cantonal Hosp, Dept Med, St Gallen, Switzerland
关键词
D O I
10.1097/00002030-200110190-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A single-nucleotide polymorphism (3'322C/G) was identified in the gene encoding a key cholesterol/triglyceride regulator, sterol-regulatory element-binding protein 1c (SREBP-1c). Although it did not alter the amino acid sequence, SREBP-1c-3'322C/G was predictive of highly active antiretroviral therapy-related hyperlipoproteinaemia. Increases in cholesterol were less frequently associated with homozygous SPEBP-1c-3'322G (genotype 22) than with heterozygous/homozygous SR-EBP-1c-3'322C (genotypes 11/12) and correlated with leptin and insulin increases, particularly in genotype 11/12 carriers. A functional mutation linked to SREBP-1c-3'322C/G or messenger RNA conformation differences may explain our findings.
引用
收藏
页码:2045 / 2049
页数:5
相关论文
共 26 条
[1]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[2]   The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance [J].
Caron, M ;
Auclair, R ;
Vigouroux, C ;
Glorian, M ;
Forest, C ;
Capeau, J .
DIABETES, 2001, 50 (06) :1378-1388
[3]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[4]   Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors [J].
Dowell, P ;
Flexner, C ;
Kwiterovich, PO ;
Lanes, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41325-41332
[5]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[6]  
Fajas L, 1999, MOL CELL BIOL, V19, P5495
[7]   Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes [J].
Foretz, M ;
Guichard, C ;
Ferré, P ;
Foufelle, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12737-12742
[8]   STRUCTURE OF THE HUMAN GENE ENCODING STEROL REGULATORY ELEMENT-BINDING PROTEIN-1 (SREBF1) AND LOCALIZATION OF SREBF1 AND SREBF2 TO CHROMOSOMES 17P11.2 AND 22Q13 [J].
HUA, XX ;
WU, J ;
GOLDSTEIN, JL ;
BROWN, MS ;
HOBBS, HH .
GENOMICS, 1995, 25 (03) :667-673
[9]   Roles of PPARs in health and disease [J].
Kersten, S ;
Desvergne, B ;
Wahli, W .
NATURE, 2000, 405 (6785) :421-424
[10]   Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].
Ledergerber, B ;
Egger, M ;
Opravil, M ;
Telenti, A ;
Hirschel, B ;
Battegay, M ;
Vernazza, P ;
Sudre, P ;
Flepp, M ;
Furrer, H ;
Francioli, P ;
Weber, R .
LANCET, 1999, 353 (9156) :863-868